Cerus Corp

CERSStocksMedical SpecialtiesUnited StatesNasdaqUSD

Price

$2.24

Today

-2.6%

YTD

+12.8%

About

Cerus is an innovative healthcare company founded in 1991 and headquartered in Concord, California. Serving an international audience, the firm has created and developed the INTERCEPT Blood System to enhance blood safety for transfused blood components. Cerus trades with the ticker CERS on the NASDAQ CM. Track the CERS price chart to see if this is the right investment for you.

Price chart

Closing price history for CERS (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-67.63

P/S (TTM)2.12

P/B (TTM)6.73

Market cap$471.57M

Cap tierSmall-cap

Industry avg P/E17.60

Profitability

Gross margin51.84%

EBIT margin-12.67%

Net margin-5.12%

ROE-10.81%

ROA-3.24%

Earnings & Revenue

Revenue (TTM)$221.55M

Revenue growth (1Y)+15.1%

EPS (TTM)-$0.03

Free cash flow$-2.00M

Total debt$76.80M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.81

Employees275

Next earnings5 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.